IMG- phellinus linteus mycelium tablet

IMG by

Drug Labeling and Warnings

IMG by is a Otc medication manufactured, distributed, or labeled by Yein Trading & Global Co., Ltd, Han Kook Sin Yak Pharmaceutical Co., Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

phellinus linteus mycelium

INACTIVE INGREDIENT

Zinc gluconate 3% (14.34% as Zinc), Vitamin C 10% (100% as vitamin C), Lactose 41%, Cordyceps militaris extract powder (mycelium culture) 6%, Chaga mushroom extract powder (mycelium culture) 6%, Ganoderma lucidum extract powder (mycelium culture) 6%, Trametes versicolor extract powder (mycelium culture) 6%, Grifola frondosa (mycelium culture) 6%, Hydroxypropylmethyl-cellulose 4%, Cultured Wild ginseng root powder 3%, Carboxymethylcellulose calcium 2%, Magnesium stearate 1%

PURPOSE

antitumor effect
prophylactic effect
immunostimulating effect
synergistic effect

KEEP OUT OF REACH OF CHILDREN

keep out of reach of the children

INDICATIONS & USAGE

1. ulterine hemorrhage and hysterorrhea, dysmenorrhea, intestinal hemorrhage, activation of five organs and stomach function, detoxication
2. reinforcement of immune function by administration in parallel with any chemical therapy after any excising operation form the patient with cancer in digestive system or liver

WARNINGS

- digestive system:  occasionally, vomiturition, vomiting, loss of appetite and diarrhea might occur, and infrequently malaise in stomach might take place
- the others:  dizziness (1 case), headache (1 case), constipation (3 cases) were reported in clinical test of this medicine

DOSAGE & ADMINISTRATION

- uterine hemorrhage and hysterorrhea, dysmenorrhea, intestinal hemorrhage, activation of five organs and stomach function, detoxication : as a phellinus linteus mycelia extracts, administer 550~1100mg 2 times per a day before having a meal by mouth
- reinforcement of immune function by administration in parallel with any chemical therapy after any excising operation for the patient with cancer in digestive system or liver :  as a phellinus linteus mycelia extracts, administer 1100mg 3 times per a day after having a meal by mouth

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

IMG 
phellinus linteus mycelium tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 53144-3001
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
PHELLINUS LINTEUS MYCELIUM (UNII: 40K19XJV3C) (PHELLINUS LINTEUS MYCELIUM - UNII:40K19XJV3C)	PHELLINUS LINTEUS MYCELIUM	0.022

Inactive Ingredients
Ingredient Name	Strength
ZINC GLUCONATE (UNII: U6WSN5SQ1Z)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
LACTOSE (UNII: J2B2A4N98G)
REISHI (UNII: TKD8LH0X2Z)
TRAMETES VERSICOLOR FRUITING BODY (UNII: 4C900477MT)
GRIFOLA FRONDOSA WHOLE (UNII: O238UC53ET)
HYPROMELLOSES (UNII: 3NXW29V3WO)
CARBOXYMETHYLCELLULOSE CALCIUM (UNII: UTY7PDF93L)
MAGNESIUM STEARATE (UNII: 70097M6I30)

Product Characteristics
Color	brown (light brown)	Score	no score
Shape	OVAL (pill)	Size	15mm
Flavor		Imprint Code	3;hp;x
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 53144-3001-1	60 in 1 BOTTLE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		02/16/2013

Labeler - Yein Trading & Global Co., Ltd (557803795)

Registrant - Yein Trading & Global Co., Ltd (557803795)

Establishment
Name	Address	ID/FEI	Business Operations
Han Kook Sin Yak Pharmaceutical Co., Ltd.		689277536	manufacture(53144-3001)